N-(4-chloro-2-methylphenyl)-2-(2-chlorophenyl)-4-(trifluoromethyl)thiazole-5-carboxamide

ID: ALA5277872

Max Phase: Preclinical

Molecular Formula: C18H11Cl2F3N2OS

Molecular Weight: 431.27

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(Cl)ccc1NC(=O)c1sc(-c2ccccc2Cl)nc1C(F)(F)F

Standard InChI:  InChI=1S/C18H11Cl2F3N2OS/c1-9-8-10(19)6-7-13(9)24-16(26)14-15(18(21,22)23)25-17(27-14)11-4-2-3-5-12(11)20/h2-8H,1H3,(H,24,26)

Standard InChI Key:  XPDAMVRWGHRCCC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   -3.9594   -0.9186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9594   -1.7436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2460   -2.1500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5389   -1.7399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5389   -0.9182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2477   -0.5080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8273   -0.5074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8273    0.3142    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0265    0.5633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5577   -0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0477   -0.7522    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.2639   -0.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6747    0.6241    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4964    0.6241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9075    1.3355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7267    1.3355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1377    0.6230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7303   -0.0905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9090   -0.0905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9594    0.6230    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    1.4967    2.0472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6747   -0.7991    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8138    1.3570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3949    1.9381    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0202    1.5697    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6012    2.1507    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8273   -2.1507    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  2  0
  5  7  1  0
  8  7  2  0
  8  9  1  0
  9 10  2  0
 11 10  1  0
  7 11  1  0
 10 12  1  0
 12 13  1  0
 13 14  1  0
 15 14  2  0
 16 15  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 14 19  1  0
 17 20  1  0
 15 21  1  0
 12 22  2  0
  9 23  1  0
 23 24  1  0
 23 25  1  0
 23 26  1  0
  4 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5277872

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-8 (3484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 431.27Molecular Weight (Monoisotopic): 429.9921AlogP: 6.70#Rotatable Bonds: 3
Polar Surface Area: 41.99Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.93CX Basic pKa: CX LogP: 6.87CX LogD: 6.87
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.50Np Likeness Score: -2.08

References

1. Sharma PC, Bansal KK, Sharma A, Sharma D, Deep A..  (2020)  Thiazole-containing compounds as therapeutic targets for cancer therapy.,  188  [PMID:31926469] [10.1016/j.ejmech.2019.112016]

Source